Evaluating immune modulator drugs for COVID-19 treatment in hospitalized adults
ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSI
This study is looking at how well three different immune system drugs work for treating COVID-19 by collecting and analyzing samples from adults in the hospital, and your participation could help us understand their safety and benefits for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Technical Resources International, INC. NIH-funded |
| Lab location | 1 site (Bethesda, United States) |
| Project ID | NIH-10722555 on NIH RePORTER |
What this research studies
This research focuses on the long-term storage, distribution, and analysis of biospecimens collected from hospitalized adults participating in a clinical trial. The trial aims to assess the safety and effectiveness of three different immune modulator drugs in treating COVID-19. By analyzing these biospecimens, researchers hope to gain insights into how these drugs work and their potential benefits for patients. Participation in this research may involve providing biological samples, which will be carefully stored and analyzed over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized adults aged 21 and older who are receiving treatment for COVID-19.
Not a fit: Patients who are not hospitalized or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options for hospitalized adults suffering from COVID-19.
How similar studies have performed: Previous research has shown promise in using immune modulators for treating COVID-19, indicating that this approach may yield valuable insights.
Where this research is happening
Bethesda, United States
- Technical Resources International, INC. — Bethesda, United States (Active)
Researchers
- Principal investigator: Butler, Sandra — Technical Resources International, INC.
- Study coordinator: Butler, Sandra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.